NDC Code(s) : 54771-1001-1
Packager : Zoetis Inc.
Category : PRESCRIPTION ANIMAL DRUG LABEL
DEA Schedule : none
Marketing Status : New Animal Drug Application
INGREDIENTS AND APPEARANCE
| Hylartin Vhyaluronate sodium INJECTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
| LABELER - Zoetis Inc.(828851555) |
PRINCIPAL DISPLAY PANEL
2ml
HYLARTIN
® V
sodium hyaluronate
injection 10 mg/mL
Caution
Federal law restricts this drug to
use by or on the order of a licensed
veterinarian
Sterile
Contents : One 2 mL syringe
Each mL contains: Sodium hyaluronate
10.0 mg, sodium chloride 8.5 mg,
disodium hydrogen phosphate
dihydrate 0.28 mg, sodium dihydrogen
phosphate hydrate 0.04 mg, water for
injection USP q.s.
Do not use in horses intended for human
consumption.
Dosage: 2 mL, carpal-fetlock/4 mL, hock
See package insert
Do not use if numerous small air
bubbles are present throughout the
solution
For intra-articular injection in horses
only.
Store at 2° to 8°C
Protect from freezing
Protect from light
NADA 112-048, Approved by FDA
Made in Sweden by:
AMO Uppsala AB, Rapsgatan 7
Box 6406, SE-751 36 Uppsala, Sweden
zoetis
Distributed by:
Zoetis Inc.
Kalamazoo, MI 49007
